Found 678 results
[ Author(Desc)] Keyword Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Bhattacharya N, Indra AK, Ganguli-Indra G.  2020.  Healing of Full-Thickness Murine Skin Wounds Containing Nanofibers Using Splints for Efficient Reepithelialization and to Avoid Contracture.. Methods Mol Biol. 2155:115-123.
Bhattacharya N, Sato WJ, Kelly A, Ganguli-Indra G, Indra AK.  2019.  Epidermal Lipids: Key Mediators of Atopic Dermatitis Pathogenesis.. Trends Mol Med. 25(6):551-562.
Bhattacharya N, Ganguli-Indra G, Indra AK.  2019.  Transcriptional control and transcriptomic analysis of lipid metabolism in skin barrier formation and atopic dermatitis (AD).. Expert Rev Proteomics. 16(8):627-645.
Blatt DH, Leonard SW, Traber MG.  2001.  Vitamin E kinetics and the function of tocopherol regulatory proteins.. Nutrition. 17(10):799-805.
Blum CA, Xu M, Orner GA, G Díaz D, Li Q, Dashwood WMohaiza, Bailey GS, Dashwood RH.  2003.  Promotion versus suppression of rat colon carcinogenesis by chlorophyllin and chlorophyll: modulation of apoptosis, cell proliferation, and beta-catenin/Tcf signaling.. Mutat Res. 523-524:217-23.
Blum CA, Xu M, Orner GA, Fong AT, Bailey GS, Stoner GD, Horio DT, Dashwood RH.  2001.  beta-Catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol.. Carcinogenesis. 22(2):315-20.
Blum CA, Tanaka T, Zhong X, Li Q, Dashwood W-M, Pereira C, Xu M, Dashwood RH.  2003.  Mutational analysis of Ctnnb1 and Apc in tumors from rats given 1,2-dimethylhydrazine or 2-amino-3-methylimidazo[4,5-f]quinoline: mutational 'hotspots' and the relative expression of beta-catenin and c-jun.. Mol Carcinog. 36(4):195-203.
Blumberg JB, Frei BB, Fulgoni VL, Weaver CM, Zeisel SH.  2017.  Impact of Frequency of Multi-Vitamin/Multi-Mineral Supplement Intake on Nutritional Adequacy and Nutrient Deficiencies in U.S. Adults.. Nutrients. 9(8)
Blumberg JB, Frei B, Fulgoni VL, Weaver CM, Zeisel SH.  2017.  Contribution of Dietary Supplements to Nutritional Adequacy by Socioeconomic Subgroups in Adults of the United States.. Nutrients. 10(1)
Blumberg JB, Cena H, Barr SI, Biesalski HKonrad, Dagach RUauy, Delaney B, Frei B, González MIgnacio Mo, Hwalla N, Lategan-Potgieter R et al..  2018.  The Use of Multivitamin/Multimineral Supplements: A Modified Delphi Consensus Panel Report.. Clin Ther. 40(4):640-657.
Blumberg JB, Frei B, Fulgoni VL, Weaver CM, Zeisel SH.  2017.  Contribution of Dietary Supplements to Nutritional Adequacy in Various Adult Age Groups.. Nutrients. 9(12)
Blumberg JB, Frei B, Fulgoni VL, Weaver CM, Zeisel SH.  2017.  Contribution of Dietary Supplements to Nutritional Adequacy in Race/Ethnic Population Subgroups in the United States.. Nutrients. 9(12)
Blumberg JB, Frei B, Fulgoni VL, Weaver CM, Zeisel SH.  2016.  Vitamin and Mineral Intake Is Inadequate for Most Americans: What Should We Advise Patients About Supplements? J Fam Pract. 65(9 Suppl):S1-S8.
Bobe G, Michels AJ, Zhang W-J, Purnell JQ, Woffendin C, Pereira C, Vita JA, Thomas NO, Traber MG, Frei B et al..  2020.  A Randomized Controlled Trial of Long-Term (R)-α-Lipoic Acid Supplementation Promotes Weight Loss in Overweight or Obese Adults without Altering Baseline Elevated Plasma Triglyceride Concentrations.. J Nutr. 150(9):2336-2345.
Bobe G, Zhang Z, Kopp R, Garzotto M, Shannon J, Takata Y.  2020.  Phytol and its metabolites phytanic and pristanic acids for risk of cancer: current evidence and future directions.. Eur J Cancer Prev. 29(2):191-200.
Bobe G, Zhang Z, Kopp R, Garzotto M, Shannon J, Takata Y.  2020.  Phytol and its metabolites phytanic and pristanic acids for risk of cancer: current evidence and future directions.. Eur J Cancer Prev. 29(2):191-200.
Bobe G, Cobb TJ, Leonard SW, Aponso S, Bahro CB, Koley D, Mah E, Bruno RS, Traber MG.  2017.  Increased static and decreased capacity oxidation-reduction potentials in plasma are predictive of metabolic syndrome.. Redox Biol. 12:121-128.
Bolton JL, Dunlap TL, Hajirahimkhan A, Mbachu O, Chen S-N, Chadwick L, Nikolic D, van Breemen RB, Pauli GF, Dietz BM.  2019.  The Multiple Biological Targets of Hops and Bioactive Compounds.. Chem Res Toxicol. 32(2):222-233.
Boulikas T.  1992.  Evolutionary consequences of nonrandom damage and repair of chromatin domains.. J Mol Evol. 35(2):156-80.
Boulikas T.  1992.  Homeotic protein binding sites, origins of replication, and nuclear matrix anchorage sites share the ATTA and ATTTA motifs.. J Cell Biochem. 50(2):111-23.
Boulikas T.  1992.  Poly(ADP-ribose) synthesis in blocked and damaged cells and its relation to carcinogenesis.. Anticancer Res. 12(3):885-98.
Boulikas T.  1992.  Poly(ADP-ribose) synthesis and degradation in mammalian nuclei.. Anal Biochem. 203(2):252-8.
Boulikas T.  1993.  Poly(ADP-ribosyl)ation, DNA strand breaks, chromatin and cancer.. Toxicol Lett. 67(1-3):129-50.
Boulikas T, Poirier GG.  1992.  Resistance of ADP-ribosylated histones and HMG proteins to proteases.. Biochem Cell Biol. 70(10-11):1258-67.
Brand EF, Lakey B, Berman S.  1995.  A preventive, psychoeducational approach to increase perceived social support.. Am J Community Psychol. 23(1):117-35.

Pages